Thank you very much, Mr. Chair.
Good evening, everyone, and welcome to our committee.
Mr. Praznik, you're in the heart of our thinking when we see Bill S-5 because you're in the business where your product is in direct contact with people.
First of all, let's talk about the watch-list. I think you have some concern with that. Can you explain your position on that?